WEI HU to Carcinoma, Squamous Cell
This is a "connection" page, showing publications WEI HU has written about Carcinoma, Squamous Cell.
Connection Strength
0.088
-
Progressive dysregulation of proliferation during cervical carcinogenesis as measured by MPM-2 antibody staining. Cancer Epidemiol Biomarkers Prev. 1997 Sep; 6(9):711-8.
Score: 0.049
-
Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry. Clin Exp Metastasis. 2002; 19(4):319-26.
Score: 0.017
-
Phase II study of carboplatin and liposomal doxorubicin in patients with recurrent squamous cell carcinoma of the cervix. Cancer. 2001 Nov 01; 92(9):2327-33.
Score: 0.016
-
Cervical chromosome 9 polysomy: validation and use as a surrogate endpoint biomarker in a 4-HPR chemoprevention trial. Gynecol Oncol. 2005 Dec; 99(3 Suppl 1):S32-7.
Score: 0.005